Complex I and the cAMP cascade in human physiopathology

S Papa1, S Scacco, A M Sardanelli

  • 1Department of Medical Biochemistry and Biology, University of Bari, Italy. papabchm@cimedoc.uniba.it

Bioscience Reports
|November 7, 2002
PubMed

Insights

Mitochondrial cAMP-dependent protein kinase (PKA) phosphorylates Complex I, enhancing respiratory activity. Mutations in the NDUFS4 gene linked to Complex I deficiency cause fatal neurological disorders.

Area of Science:

  • Mitochondrial biochemistry
  • Cellular respiration
  • Molecular genetics

Background:

  • Mitochondria contain cAMP-dependent protein kinase (PKA) that phosphorylates proteins on the matrix side of the inner membrane.
  • Complex I of the respiratory chain includes an 18 kDa subunit (encoded by NDUFS4) that is a substrate for mitochondrial PKA.
  • Mitochondria possess a Ca(2+)-inhibited phosphatase that dephosphorylates this 18 kDa subunit.

Purpose of the Study:

  • To investigate the role of cAMP-dependent phosphorylation of the 18 kDa subunit of Complex I in regulating mitochondrial respiratory activity.
  • To explore the functional consequences of NDUFS4 gene mutations associated with Complex I deficiency.

Main Methods:

  • Studies were conducted using fibroblast and myoblast cell cultures.
  • Assessed the impact of cAMP-dependent phosphorylation on Complex I activity and overall respiratory function with NAD-linked substrates.

Main Results:

  • cAMP-dependent phosphorylation of the 18 kDa protein was associated with increased Complex I activity.
  • This phosphorylation event correlated with enhanced overall respiratory activity when using NAD-linked substrates.
  • Mutations in the human NDUFS4 gene, when homozygous, lead to Complex I deficiency and a fatal neurological syndrome.

Conclusions:

  • Mitochondrial PKA-mediated phosphorylation of the NDUFS4-encoded 18 kDa subunit is a regulatory mechanism for Complex I and cellular respiration.
  • Dysfunction of this regulatory pathway, as seen in NDUFS4 mutations, can result in severe mitochondrial disease and neurological impairment.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.